Depurative capacity of molecular adsorbent recycling system (MARS): A focus on bilirubin removal

International Journal of Artificial Organs

Volumn 31, Issue 10, 2008, Pages 875-881

  Gong, D ^a   Cruz, D ^b   Ronco, Claudio ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Albumin bound toxin bilirubin; Hepatic failure; Molecular adsorbent recycling system

Indexed keywords

PATIENT TREATMENT; RECYCLING;

% REDUCTIONS; ALBUMIN BINDINGS; ALBUMIN-BOUND TOXIN BILIRUBIN; BILIRUBIN REMOVAL; BLOOD PURIFICATION; CLINICAL OUTCOME; FREE FRACTION; HEPATIC FAILURE; MOLECULAR ADSORBENT RECYCLING SYSTEM; RECYCLING SYSTEMS;

TOXIC MATERIALS;

ALBUMIN; BILIRUBIN; TOXIN;

ALBUMIN DIALYSIS; BINDING AFFINITY; DIFFUSION; HUMAN; IONIC STRENGTH; LIVER FAILURE; OUTCOME ASSESSMENT; PH; PROTEIN BINDING; REVIEW;

EID: 59549103734     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803101003     Document Type: Review

References (31)

1. Meyer TW, Walther JL, Pagtalunan ME, et al. The clearance of protein-bound solutes by hemofiltration and hemodiafiltration. Kidney Int 2005; 68: 867-77.
2. Mitzner SR, Stange J, Klammt S, et al. Albumin dialysis using the molecular adsorbent recirculating system. Curr Opin Nephrol Hypertens 2001; 10: 777-83.
3. Khuroo MS, Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-onchronic liver failure: a meta-analysis. Liver Transpl 2004; 10: 1099-106.
4. Choi JY, Bae SH, Yoon SK, et al. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation - a pilot study. Liver Int 2005; 25: 740-5.
5. Lai WK, Haydon G, Mutimer D, et al. The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure. Intensive Care Med 2005; 31: 1544-9.
6. Awad SS, Swaniker F, Bartlett RH. Preliminary results of a phase I trial evaluating an extracorporeal hepatic support device utilizing albumin dialysis. Z Gastroenterol 2001; 39 (suppl 2): S22-3.
7. Laleman W, Wilmer A, Evenepoel P, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006; 10: R108.
8. Tan HK, Yang WS, Chow P, Lui HF, Choong HL, Wong KS. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system. Int J Artif Organs 2007; 31: 193-9.
9. Zhou X, Miao J, Yang Y, et al. Clinical experience with molecular adsorbent recirculating system (MARS) in patients with drug-induced liver failure. Artif Organs 2004; 28: 483-6.
10. Chen S, Zhang L, Shi Y, et al. Molecular adsorbent recirculating system: clinical experience in patients with liver failure based on hepatitis B in China. Liver 2002; 22 (suppl 2): S48-51.
11. Guo LM, Liu JY, Xu DZ, et al. Application of molecular adsorbents recirculating system to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver Int 2003; 23 (suppl 3): S16-20.
12. Prokurat S, Grenda R, Lpowski D, et al. MARS procedure as a bridge to combined liver-kidney transplantation in severe chromium-copper acute intoxication: a paediatric case report. Liver 2002; 22 (suppl 2): S76-7.
13. Lee KH, Wendon J, Lee M, et al. Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin. Liver Transpl 2002; 8: 591-3.
14. Evenepoel P, Maes B, Wilme A, et al. Detoxifying capacity and kinetics of molecular adsorbent recycling system. Blood Purif 2003; 21: 244-52.
15. Evenepoel P, Laleman W, Wilmer A, et al. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Int J Artif Organs 2006; 30: 276-84.
16. Krisper P, Haditsch B, Stauber R, et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005; 43: 451-7.
17. Peszynski P, Klammt S, Peters E, et al. Albumin dialysis: single pass vs. recirculation (MARS). Liver 2002; 22 (suppl 2): S40-2.
18. Magosso E, Ursino M, Coli L, et al. A modeling study of bilirubin kinetics during molecular adsorbent recirculation system sessions. Int J Artif Organs 2006; 30: 285-300.
19. Wilmer A, Nevens F, Evenepoel P, et al. The molecular adsorbent recirculating system in patients with severe liver failure: clinical results at K.U. Leuven. Liver 2002; 22 (suppl 2): S52-5.
20. Abe T, Shono M, Kodama T, et al. Extracorporeal albumin dialysis. Ther Apher Dial 2004; 8: 217-22.
21. Kozaki N, Shimizu S, Higashijima H, et al. Significance of serum delta-bilirubin in patients with obstructive jaundice. J Surg Res 1998; 79: 61-5.
22. Moosavi-Movahedi Z, Safarian S, Zahedi M, et al. Calorimetric and binding dissections of HSA upon interaction with bilirubin. Protein J 2006; 25: 193-201.
23. Ostrow JD, Mukerjee P, Tiribelli C. Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res 1994; 35: 1715-37.
24. Roca LY, Calligaris S, Wennberg RP, et al. Factors affecting the binding of bilirubin to serum albumins: validation and application of the peroxidase method. Pediatr Res 2006; 60: 724-8.
25. Ostrow JD, Pascolo L, Tiribelli C. Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr Res 2003; 54: 98-104.
26. Nevens F, Wilmer A, Vanrenterghem Y. The molecular adsorbent recycling system (MARS) and transmembrane transport of albumin-bound toxins. Liver Transpl 2005; 11: 853-5.
27. Weisiger RA, Ostrow JD, Koehler RK, et al. Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition. J Biol Chem 2001; 276: 29953-60.
28. Hinderling PH, Hartmann D. The pH dependency of the binding of drugs to plasma proteins in man. Ther Drug Monit 2005; 27: 71-85.
29. Rashid H, Ali MK, Tayyab S. Effect of pH and temperature on the binding of bilirubin to human erythrocyte membranes. J Biosci 2000; 25: 157-61.
30. Brodersen R. Competitive binding of bilirubin and drugs to human serum albumin studied by enzymatic oxidation. J Clin Invest 1974; 54: 1353-64.
31. Wadsworth SJ, Suh B. In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns. Antimicrob Agents Chemother 1988; 32: 1571-5.